Literature DB >> 22631666

Survival and prognostic factors of different sites of head and neck cancer: an analysis from Thailand.

Kowit Pruegsanusak1, Sumet Peeravut, Vitoon Leelamanit, Wattana Sinkijcharoenchai, Jaturong Jongsatitpaiboon, Temsak Phungrassami, Kanyarat Chuchart, Paramee Thongsuksai.   

Abstract

BACKGROUND: Head and neck cancers are prevalent in Thailand, in particular in the southern region of the country. However, survival with a large data set has not been reported. The purpose of the present study was to evaluate the survival figures and the prognostic factors in a cohort of patients treated in a university hospital located in the south of Thailand. PATIENTS AND METHODS: Consecutive new cases of primary carcinoma of the oral cavity, oropharyx, hypopharynx and larynx, treated at Songklanagarind Hospital during 2002 to 2004, were analyzed. The 5-year overall survival rates were obtained by the Kaplan-Meier method. Prognostic factors were identified through multivariate Cox regression analysis.
RESULTS: A total 1,186 cases were analyzed. Two-thirds (66.6%) of the cases were at advanced stage (stage III and IV) at presentation. The five-year overall survivals for the whole cohort, oral cavity, oropharynx, hypopharynx and larynx were 24.1%, 25.91%, 19.2%, 13.4%, 38.0% respectively. Stage and treatment type were strong prognostic factors for all sites. An age ≥80 years was associated with poor survival in oral cavity and larynx cancer.
CONCLUSIONS: The results revealed remarkably poor outcomes of the patients in the series, indicating a strong need to increase the proportion of early stage presentations and maximize the treatment efficacy to improving outcomes. Very old patients are of particular concern for treatment care of oral cavity and larynx cancer.

Entities:  

Mesh:

Year:  2012        PMID: 22631666     DOI: 10.7314/apjcp.2012.13.3.885

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  15 in total

1.  Platelet to lymphocyte ratio and red cell distribution width as prognostic factors for survival and recurrence in patients with oral cancer.

Authors:  Manupol Tangthongkum; Sireethorn Tiyanuchit; Virat Kirtsreesakul; Pasawat Supanimitjaroenporn; Wattana Sinkitjaroenchai
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-02       Impact factor: 2.503

2.  Knowledge and Health Belief Attitudes of Oral Cancer and Its Screening Among At-Risk Southern Thai Muslims.

Authors:  Srisuk Khwankong; Hutcha Sriplung; Duangporn Kerdpon
Journal:  J Cancer Educ       Date:  2018-06       Impact factor: 2.037

3.  DIRC3 and near NABP1 genetic polymorphisms are associated laryngeal squamous cell carcinoma patient survival.

Authors:  Zhen Shen; Wanli Ren; Yanxia Bai; Zhengshuai Chen; Jingjie Li; Bin Li; Tianbo Jin; Peilong Cao; Yuan Shao
Journal:  Oncotarget       Date:  2016-11-29

4.  Analysis of primary oral and oropharyngeal squamous cell carcinoma in inhabitants of Beijing, China-a 10-year continuous single-center study.

Authors:  Xue-Xiao Bai; Jie Zhang; Li Wei
Journal:  BMC Oral Health       Date:  2020-07-17       Impact factor: 2.757

5.  Development and Validation of a Nomogram based on cell growth-related Biomarkers for Oral Squamous Cell Carcinoma.

Authors:  Yanjie Shuai; Yuansheng Duan; Mengqian Zhou; Kai Yue; Dandan Liu; Yan Fang; Yuxuan Wang; Yansheng Wu; Ze Zhang; Xudong Wang
Journal:  J Cancer       Date:  2021-06-22       Impact factor: 4.207

6.  Genomic Alteration in Head and Neck Squamous Cell Carcinoma (HNSCC) Cell Lines Inferred from Karyotyping, Molecular Cytogenetics, and Array Comparative Genomic Hybridization.

Authors:  Worapong Singchat; Ekarat Hitakomate; Budsaba Rerkarmnuaychoke; Aorarat Suntronpong; Beiyuan Fu; Winai Bodhisuwan; Surin Peyachoknagul; Fengtang Yang; Sittichai Koontongkaew; Kornsorn Srikulnath
Journal:  PLoS One       Date:  2016-08-08       Impact factor: 3.240

7.  Asian expert recommendation on management of skin and mucosal effects of radiation, with or without the addition of cetuximab or chemotherapy, in treatment of head and neck squamous cell carcinoma.

Authors:  Guopei Zhu; Jin-Ching Lin; Sung-Bae Kim; Jacques Bernier; Jai Prakash Agarwal; Jan B Vermorken; Dang Huy Quoc Thinh; Hoi-Ching Cheng; Hwan Jung Yun; Imjai Chitapanarux; Prasert Lertsanguansinchai; Vijay Anand Reddy; Xia He
Journal:  BMC Cancer       Date:  2016-01-27       Impact factor: 4.430

8.  Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival.

Authors:  Kambiz Novin; Ahmad Ameri; Saba Faraji; Peyman Torbati; Nafiseh Mortazavi
Journal:  Iran J Cancer Prev       Date:  2015-10-27

9.  The mortality-incidence ratio as an indicator of five-year cancer survival in metropolitan Lima.

Authors:  Karoline Stenning-Persivale; Maria Jose Savitzky Franco; Alejandra Cordero-Morales; José Cruzado-Burga; Ebert Poquioma; Edgar Díaz Nava; Eduardo Payet
Journal:  Ecancermedicalscience       Date:  2018-01-18

10.  Oral and oropharyngeal cancer: epidemiology and survival analysis.

Authors:  Juliana da Silva Moro; Marília Cunha Maroneze; Thiago Machado Ardenghi; Luisa Machado Barin; Cristiane Cademartori Danesi
Journal:  Einstein (Sao Paulo)       Date:  2018-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.